Skip to content Skip to navigation

Your Money

This federal securities fraud class action lawsuit is brought against Nobilis Health Corp., a company acquiring and managing ambulatory surgery centers and healthcare facilities, for making false and misleading material statements, including the following: (a) Nobilis claimed success rates for its AccuraScope procedure, which lacked recognition from any university, medical body, or insurance company; (b) Nobilis overstated its 2014 revenues by over $36 million and its 2014 revenue growth rate as 161%, when it was actually only 44%. These statements caused Nobilis’s stock to trade at artificially inflated prices which caused financial loss to the Plaintiffs.

This securities fraud class action lawsuit is brought against Valeant Pharmaceuticals International, Inc. for making false material statements: (a) deceived the investing public regarding Valeant’s prospects and business; (b) omitted disclosure of key aspects of the Valeant’s business, specifically its relationship with a network of specialty pharmacies utilized to boost sales of Valeant’s high-priced drugs; (c) Valeant’s undisclosed use of specialty pharmacies left it subject to increased regulatory risks that investors were unable to account for; (d) without use of specialty pharmacies, Valeant’s financial performance and financial guidance would have been negatively impacted.

Navient Logo

This lawsuit alleges that Navient, the successor entity to student lender Sallie Mae, charged student loan interest rates to California borrowers that were in excess of the 10% annual interest rate limit permitted by California Usury laws.

Amicus Therapeutics Logo

This securities class action alleges that Amicus Therapeutics made false, misleading and material representations to the market regarding a meeting held with the U.S. Food and Drug Administration regarding the development of the company's new drug, migalasta.

China Cache Logo

This class action lawsuit alleges ChinaCache made false statements and failing to disclose that (1) the platform migration to High Performance Cloud Cache (HPCC) was not successful.

The Wayne County Employees' Retirement System, a shareholder in the FMI Large Cap Fund (the "Fund"), has filed this derivative lawsuit alleging that the Board of Fiduciary Management, Inc. extracted higher investment advisory fees from the captive Fund than from arm's length institutional clients, even where the advisory services provided to those arm's length clients were substantially similar and in some cases identical to those FMI provided the fund.

This investigation concerns the Direxion Daily Gold Miners Bull 3x Shares, a three-time leveraged exchange-traded fund (ETF) which trades on NYSE under ticker symbol NUGT.  Leveraged ETF’s such as NUGT are designed as a product for day-traders and are not typically supposed to be recommended as “buy and hold” investments. Claims have been brought on behalf of investors who have suffered losses due to their brokers making such recommendations, which violate suitability rules.

This class action lawsuit is brought against USA Technologies alleging failure to disclose (1) significant deficiencies in both the design and operating effectiveness of the company’s internal control over financial reporting; and (2) as a result of these deficiencies, USA Technologies’ procedures failed to identify a large number of uncollectible small balance accounts.

This securities fraud class action alleges that Globus, a medical device company, failed to disclose (1) its relationship with a significant distributor was deteriorating; (2) the deterioration negatively impacted Globus’s financial performance; and (3) as a result, Globus’s prospects and statements were false and misleading.

This lawsuit alleges that Volkswagen AG made materially false and misleading statements and omissions to investors concerning company operations, financial condition and outlook and specifically failed to disclose that it had utilized a "defeat device" in certain diesel cars which allowed the vehicles to temporarily reduce emissions during testing yet emit at dramatically higher levels outside of testing conditions.